In conclusion, we demonstrated that silencing LTBP2 significantly reduced cisplatin resistance and inhibited the proliferation ability of GC cells by silencing LTBP2 in wild-type and cisplatin-resistant HGC-27 cells in this study. This evidence concerns the gene LTBP2 and gastric cancer.